Anixa Biosciences Inc (NASDAQ: ANIX) stock enjoyed a major increase of 19.8% on 3/15/24. The shares closed at $3.69. Moreover, exceptionally high trading volume at 224% of normal accompanied the advance. The stock has been strong relative to the market over the last nine months and has risen 7.0% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, ANIX is expected to continue to be a modest Value Eraser.
Anixa Biosciences has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Anixa Biosciences has a very low Appreciation Score of 4 but a slightly positive Power Rating of 68, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment